尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Crowley John J, 首席财务官. Insider active across 2 companies, notably Fusion Pharmaceuticals Inc.. In total, 4 disclosures have been recorded. Activity tracked since 2 February 2026. The latest transaction was filed on 2 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
John J. Crowley is the Chief Financial Officer of Fusion Pharmaceuticals Inc. He is responsible for the financial management of the company, including financial planning and analysis. His expertise is crucial to support Fusion Pharmaceuticals' growth strategy.